Jian Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jian Zhang has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Jiangang Gao
School of Life Science, Shandong University, Qingdao, China.
8 shared publications Aizhen Zhang
School of Life Science and Key Laboratory of the Ministry of Education for Experimental Teratology, Shandong University, Jinan, China
5 shared publicationsTingting Zhang
State Key Laboratory of Microbial Technology, Microbial Technology Institute, Shandong University, Qingdao, Shandong, China
4 shared publicationsXinyu Dong
School of Life Sciences, Shandong University, Qingdao, 266237, Shandong, China
4 shared publicationsHaixia Zhu
Department of Pharmacology, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China
3 shared publicationsMingyu Wang
State Key Laboratory of Microbial Technology, Microbial Technology Research Institute, Shandong University, Qingdao 266237, China
3 shared publications
Latest Publications
- Open Access
- 14 August 2026
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 12 (1) , 293
All-optical strategy for high-speed and subcellular precision drug delivery using Airy beams
Drug delivery strategies with excellent spatiotemporal controllability and biocompatibility hold exciting prospects in personalized medicine and biopharmaceuticals. Among them, all-optical delivery strategies have attracted significant attention due to their low invasiveness and high positioning accuracy. However, current all-optical schemes predominantly rely on conservative optical gradient force trapping or transient scattering forces propulsion, which cannot sustain stable driving and limit delivery speed. Here, we present an all-optical delivery strategy based on Airy beam, enabling high-speed and subcellular-precision delivery through the synergistic regulation of gradient-scattering forces. The dominant scattering force of Airy beams propels drug carriers at speeds exceeding 400 µm/s, while the gradient force ensures a subcellular delivery precision of ~1 µm during high-speed propulsion. Quantitative measurements using a custom axial imaging module reveal at least a 7-fold speed enhancement over conventional all-optical methods. When applied to anticancer drug delivery, the localized mechanical forces generated by high-speed propulsion enhance stable adhesion of carriers to the cell membrane, thereby promoting drug uptake and accelerating tumor cells apoptosis. This work establishes Airy beams as a powerful tool for drug delivery, opening a new avenue for high-performance all-optical delivery platforms.
- 14 August 2026
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 12 (1) , 293
Open AccessAll-optical strategy for high-speed and subcellular precision drug delivery using Airy beams
Drug delivery strategies with excellent spatiotemporal controllability and biocompatibility hold exciting prospects in personalized medicine and biopharmaceuticals. Among them, all-optical delivery strategies have attracted significant attention due to their low invasiveness and high positioning accuracy. However, current all-optical schemes predominantly rely on conservative optical gradient force trapping or transient scattering forces propulsion, which cannot sustain stable driving and limit delivery speed. Here, we present an all-optical delivery strategy based on Airy beam, enabling high-speed and subcellular-precision delivery through the synergistic regulation of gradient-scattering forces. The dominant scattering force of Airy beams propels drug carriers at speeds exceeding 400 µm/s, while the gradient force ensures a subcellular delivery precision of ~1 µm during high-speed propulsion. Quantitative measurements using a custom axial imaging module reveal at least a 7-fold speed enhancement over conventional all-optical methods. When applied to anticancer drug delivery, the localized mechanical forces generated by high-speed propulsion enhance stable adhesion of carriers to the cell membrane, thereby promoting drug uptake and accelerating tumor cells apoptosis. This work establishes Airy beams as a powerful tool for drug delivery, opening a new avenue for high-performance all-optical delivery platforms.
- Open Access
The proteinaceous biofilm of Gardnerella vaginalis enables a novel enzymatic therapy for bacterial vaginosis
- Open Access
- 6 September 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 303, 118991
Resistomic features and novel genetic element identified in hospital wastewater with short- and long-read metagenomics
- 6 September 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 303, 118991
Open AccessResistomic features and novel genetic element identified in hospital wastewater with short- and long-read metagenomics
- Open Access
Red Blood Cell-Based Biological Micromotors Propelled by Spiral Optical Fields
Micromotors play a crucial role in microsystems technology, with applications in nanoparticle propulsion, targeted drug delivery, and biosensing. Optical field propulsion, particularly optical tweezers (OTs), enables precise, noncontact control but traditionally relies on Gaussian traps, which require preprogramming and offer limited rotational control. Here, we introduce a micromotor driven by optical vortex beams, utilizing phase gradients to generate optical torque. This eliminates preprogramming and enables real-time control over rotation and positioning. Using this method, we design red blood cell (RBC)-based micromotors for targeted cellular debris collection in liquid environments. Our findings provide a versatile strategy for micro-/nano-object manipulation with potential applications in biomedicine and precision transport.
Open AccessRed Blood Cell-Based Biological Micromotors Propelled by Spiral Optical Fields
Micromotors play a crucial role in microsystems technology, with applications in nanoparticle propulsion, targeted drug delivery, and biosensing. Optical field propulsion, particularly optical tweezers (OTs), enables precise, noncontact control but traditionally relies on Gaussian traps, which require preprogramming and offer limited rotational control. Here, we introduce a micromotor driven by optical vortex beams, utilizing phase gradients to generate optical torque. This eliminates preprogramming and enables real-time control over rotation and positioning. Using this method, we design red blood cell (RBC)-based micromotors for targeted cellular debris collection in liquid environments. Our findings provide a versatile strategy for micro-/nano-object manipulation with potential applications in biomedicine and precision transport.
- Open Access
- 17 May 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (10) , 4815
Loxl3 Affects Palatal Shelf Elevation by Regulating Cell Proliferation and Collagen Deposition
Cleft palate is one of the most common congenital abnormalities and one of the main symptoms of Stickler syndrome. Secondary palate development is a complex multi-step process that involves raising the palatal frame from a vertical to a horizontal position. Lysyl oxidase-like 3 (LOXL3), a member of the lysyl oxidase family responsible for the crosslinking in collagen, is also one of the mutated genes detected in Stickler syndrome. Loss of Loxl3 causes delayed palatal shelf elevation, which in turn resulted in cleft palate. However, the precise mechanisms of palatal shelf delayed elevation remain unclear. In this study, we deeply investigated the mechanism of Loxl3 induced delayed elevation in palatal shelves. We found that Loxl3 deficiency caused reduced cell proliferation in both medial and posterior palatal mesenchyme through BrdU labeling and Western blot analysis (p < 0.05, p < 0.01), decreased migration of palatal mesenchymal cells through cell scratch assay (p < 0.05), and decreased expression of genes associated with proliferation through Western blot analysis (p < 0.05, p < 0.01) at E14. We found that the specific deletion of Loxl3 in the palatal mesenchyme resulted in delayed elevation but normal fusion of palatal shelves, also reduced cell proliferation and collagen fibers deposition in medial palatal mesenchyme through BrdU labeling and histological analysis (p < 0.05, p < 0.01). Thus, our data suggest that Loxl3 regulates cell proliferation and collagen fibers deposition in the palatal mesenchyme, thus controlling palatal shelf elevation.
- 17 May 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (10) , 4815
Open AccessLoxl3 Affects Palatal Shelf Elevation by Regulating Cell Proliferation and Collagen Deposition
Cleft palate is one of the most common congenital abnormalities and one of the main symptoms of Stickler syndrome. Secondary palate development is a complex multi-step process that involves raising the palatal frame from a vertical to a horizontal position. Lysyl oxidase-like 3 (LOXL3), a member of the lysyl oxidase family responsible for the crosslinking in collagen, is also one of the mutated genes detected in Stickler syndrome. Loss of Loxl3 causes delayed palatal shelf elevation, which in turn resulted in cleft palate. However, the precise mechanisms of palatal shelf delayed elevation remain unclear. In this study, we deeply investigated the mechanism of Loxl3 induced delayed elevation in palatal shelves. We found that Loxl3 deficiency caused reduced cell proliferation in both medial and posterior palatal mesenchyme through BrdU labeling and Western blot analysis (p < 0.05, p < 0.01), decreased migration of palatal mesenchymal cells through cell scratch assay (p < 0.05), and decreased expression of genes associated with proliferation through Western blot analysis (p < 0.05, p < 0.01) at E14. We found that the specific deletion of Loxl3 in the palatal mesenchyme resulted in delayed elevation but normal fusion of palatal shelves, also reduced cell proliferation and collagen fibers deposition in medial palatal mesenchyme through BrdU labeling and histological analysis (p < 0.05, p < 0.01). Thus, our data suggest that Loxl3 regulates cell proliferation and collagen fibers deposition in the palatal mesenchyme, thus controlling palatal shelf elevation.
- Open Access
- 19 December 2023
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (12) , 1-14
Gss deficiency causes age-related fertility impairment via ROS-triggered ferroptosis in the testes of mice
Glutathione synthetase (GSS) catalyzes the final step in the synthesis of glutathione (GSH), a well-established antioxidant. Research on the specific roles of the Gss gene during spermatogenesis remains limited due to the intricate structure of testis. In this study, we identified pachytene spermatocytes as the primary site of GSS expression and generated a mouse model with postnatal deletion of Gss using Stra8-Cre (S8) to investigate the role of GSS in germ cells. The impact of Gss knockout on reducing male fertility is age-dependent and caused by ferroptosis in the testis. The 2-month-old S8/Gss−/− male mice exhibited normal fertility, due to a compensatory increase in GPX4, which prevented the accumulation of ROS. With aging, there was a decline in GPX4 and an increase in ALOX15 levels observed in 8-month-old S8/Gss−/− mice, resulting in the accumulation of ROS, lipid peroxidation, and ultimately testicular ferroptosis. We found that testicular ferroptosis did not affect spermatogonia, but caused meiosis disruption and acrosome heterotopia. Then the resulting aberrant sperm showed lower concentration and abnormal morphology, leading to reduced fertility. Furthermore, these injuries could be functionally rescued by inhibiting ferroptosis through intraperitoneal injection of GSH or Fer-1. In summary, Gss in germ cells play a crucial role in the resistance to oxidative stress injury in aged mice. Our findings deepen the understanding of ferroptosis during spermatogenesis and suggest that inhibiting ferroptosis may be a potential strategy for the treatment of male infertility.
- 19 December 2023
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (12) , 1-14
Open AccessGss deficiency causes age-related fertility impairment via ROS-triggered ferroptosis in the testes of mice
Glutathione synthetase (GSS) catalyzes the final step in the synthesis of glutathione (GSH), a well-established antioxidant. Research on the specific roles of the Gss gene during spermatogenesis remains limited due to the intricate structure of testis. In this study, we identified pachytene spermatocytes as the primary site of GSS expression and generated a mouse model with postnatal deletion of Gss using Stra8-Cre (S8) to investigate the role of GSS in germ cells. The impact of Gss knockout on reducing male fertility is age-dependent and caused by ferroptosis in the testis. The 2-month-old S8/Gss−/− male mice exhibited normal fertility, due to a compensatory increase in GPX4, which prevented the accumulation of ROS. With aging, there was a decline in GPX4 and an increase in ALOX15 levels observed in 8-month-old S8/Gss−/− mice, resulting in the accumulation of ROS, lipid peroxidation, and ultimately testicular ferroptosis. We found that testicular ferroptosis did not affect spermatogonia, but caused meiosis disruption and acrosome heterotopia. Then the resulting aberrant sperm showed lower concentration and abnormal morphology, leading to reduced fertility. Furthermore, these injuries could be functionally rescued by inhibiting ferroptosis through intraperitoneal injection of GSH or Fer-1. In summary, Gss in germ cells play a crucial role in the resistance to oxidative stress injury in aged mice. Our findings deepen the understanding of ferroptosis during spermatogenesis and suggest that inhibiting ferroptosis may be a potential strategy for the treatment of male infertility.
- Open Access
- 18 December 2023
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 63 (2) , 107065
Proguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii
- 18 December 2023
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 63 (2) , 107065
Open AccessProguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii
- Open Access
Proguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii
The emergence of Acinetobacter baumannii infections as a significant healthcare concern in hospital settings, coupled with their association with poorer clinical outcomes, has prompted extensive investigation into novel therapeutic agents and innovative treatment strategies. Proguanil and chlorhexidine, both categorized as biguanide compounds, have displayed clinical efficacy as antimalarial and topical antibacterial agents, respectively. In this study, we conducted an investigation to assess the effectiveness of combining proguanil and chlorhexidine with clarithromycin or rifampicin against both laboratory strains and clinical isolates of A. baumannii . The combination therapy demonstrated rapid bactericidal activity against planktonic multidrug-resistant A. baumannii , exhibiting efficacy in eradicating mature biofilms and impeding the development of antibiotic resistance in vitro . Additionally, when administered in conjunction with clarithromycin or rifampicin, proguanil enhanced the survival rate of mice afflicted with intraperitoneal A. baumannii infections, and chlorhexidine expedited wound healing in mice with skin infections. These findings are likely attributable to the disruption of A. baumannii cell membrane integrity by proguanil and chlorhexidine, resulting in heightened membrane permeability and enhanced intracellular accumulation of clarithromycin and rifampicin. Overall, this study underscores the potential of employing proguanil and chlorhexidine in combination with specific antibiotics to effectively combat A. baumannii infections and improve treatment outcomes in clinically challenging scenarios. IMPORTANCE: A. baumannii has emerged as a globally significant nosocomial pathogen due to its remarkable ability to acquire antibiotic resistance and develop biofilms on both biotic and abiotic surfaces. Recent research has demonstrated that the antidiabetic drug metformin has a potentiation effect on doxycycline and minocycline against certain multidrug-resistant bacterial pathogens, suggesting the potential of this biguanide agent as a novel tetracyclines adjuvant. In this study, we provide evidence showing that the combination of proguanil and chlorhexidine with clarithromycin or rifampicin exhibits rapid bactericidal activities against both planktonic cells and mature biofilms of A. baumannii , the capacity to inhibit the development of antibiotic resistance and improvement of the treatment outcomes in A. baumannii -infected mice. Given the advantages of repurposing non-antibiotic drugs as antibiotic adjuvants, proguanil and chlorhexidine show promise as adjuvants of specific antibiotics in combating clinically significant pathogenic A. baumannii .
Open AccessProguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii
The emergence of Acinetobacter baumannii infections as a significant healthcare concern in hospital settings, coupled with their association with poorer clinical outcomes, has prompted extensive investigation into novel therapeutic agents and innovative treatment strategies. Proguanil and chlorhexidine, both categorized as biguanide compounds, have displayed clinical efficacy as antimalarial and topical antibacterial agents, respectively. In this study, we conducted an investigation to assess the effectiveness of combining proguanil and chlorhexidine with clarithromycin or rifampicin against both laboratory strains and clinical isolates of A. baumannii . The combination therapy demonstrated rapid bactericidal activity against planktonic multidrug-resistant A. baumannii , exhibiting efficacy in eradicating mature biofilms and impeding the development of antibiotic resistance in vitro . Additionally, when administered in conjunction with clarithromycin or rifampicin, proguanil enhanced the survival rate of mice afflicted with intraperitoneal A. baumannii infections, and chlorhexidine expedited wound healing in mice with skin infections. These findings are likely attributable to the disruption of A. baumannii cell membrane integrity by proguanil and chlorhexidine, resulting in heightened membrane permeability and enhanced intracellular accumulation of clarithromycin and rifampicin. Overall, this study underscores the potential of employing proguanil and chlorhexidine in combination with specific antibiotics to effectively combat A. baumannii infections and improve treatment outcomes in clinically challenging scenarios. IMPORTANCE: A. baumannii has emerged as a globally significant nosocomial pathogen due to its remarkable ability to acquire antibiotic resistance and develop biofilms on both biotic and abiotic surfaces. Recent research has demonstrated that the antidiabetic drug metformin has a potentiation effect on doxycycline and minocycline against certain multidrug-resistant bacterial pathogens, suggesting the potential of this biguanide agent as a novel tetracyclines adjuvant. In this study, we provide evidence showing that the combination of proguanil and chlorhexidine with clarithromycin or rifampicin exhibits rapid bactericidal activities against both planktonic cells and mature biofilms of A. baumannii , the capacity to inhibit the development of antibiotic resistance and improvement of the treatment outcomes in A. baumannii -infected mice. Given the advantages of repurposing non-antibiotic drugs as antibiotic adjuvants, proguanil and chlorhexidine show promise as adjuvants of specific antibiotics in combating clinically significant pathogenic A. baumannii .
- Open Access
Spatially and Temporally Confined Response of Gastrointestinal Antibiotic Resistance Gene Levels to Sulfadiazine and Extracellular Antibiotic Resistance Gene Exposure in Mice
This work aims to investigate the impact of antibiotics and extracellular antibiotic resistance genes (eARGs) on the dynamics of gastrointestinal antimicrobial resistance (AMR). The antibiotic resistance gene (ARG) levels of different segments of the gastrointestinal tract of mouse models were analyzed and compared after exposure to clinical concentrations of sulfadiazine and environmental levels of eARGs carried by the conjugative plasmid pR55. Exposure to sulfadiazine and eARGs led to significant changes in ARG levels by as many as four log-folds. Further analysis showed that the response of ARG levels appeared from 12–16 days after exposure and diminished 20 days after exposure. The responses in ARG levels were also restricted to different gastrointestinal segments for sulfadiazine and eARGs. Combined exposure of sulfadiazine and eARGs was unable to further increase ARG levels. From these findings, we concluded that the short-term consumption of environmental levels of eARGs and uptake of clinical levels of antibiotics lead to a spatially and temporally confined response in gastrointestinal AMR. These findings further clarify the detrimental impacts of antibiotic and eARG uptake, and the complexity of AMR development and dissemination dynamics in the gastrointestinal tract.
Open AccessSpatially and Temporally Confined Response of Gastrointestinal Antibiotic Resistance Gene Levels to Sulfadiazine and Extracellular Antibiotic Resistance Gene Exposure in Mice
This work aims to investigate the impact of antibiotics and extracellular antibiotic resistance genes (eARGs) on the dynamics of gastrointestinal antimicrobial resistance (AMR). The antibiotic resistance gene (ARG) levels of different segments of the gastrointestinal tract of mouse models were analyzed and compared after exposure to clinical concentrations of sulfadiazine and environmental levels of eARGs carried by the conjugative plasmid pR55. Exposure to sulfadiazine and eARGs led to significant changes in ARG levels by as many as four log-folds. Further analysis showed that the response of ARG levels appeared from 12–16 days after exposure and diminished 20 days after exposure. The responses in ARG levels were also restricted to different gastrointestinal segments for sulfadiazine and eARGs. Combined exposure of sulfadiazine and eARGs was unable to further increase ARG levels. From these findings, we concluded that the short-term consumption of environmental levels of eARGs and uptake of clinical levels of antibiotics lead to a spatially and temporally confined response in gastrointestinal AMR. These findings further clarify the detrimental impacts of antibiotic and eARG uptake, and the complexity of AMR development and dissemination dynamics in the gastrointestinal tract.
- 4 January 2023
- Published by Elsevier in Developmental Biology
- Vol. 495, 54-62
Progressive degeneration of the retina in Loxl3 mutant mouse model of Stickler syndrome
- 4 January 2023
- Published by Elsevier in Developmental Biology
- Vol. 495, 54-62
Progressive degeneration of the retina in Loxl3 mutant mouse model of Stickler syndrome